{"id":"W2163887249","doi":"10.1002/hep.25541","title":"Sorafenib in clinical practice: Evidence-based use or abuse?","year":2011,"lang":"en","type":"letter","venue":"Hepatology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Alberta Innovates; Fondation pour la Recherche Médicale","keywords":"Sorafenib; Medicine; Randomized controlled trial; Internal medicine; Dosing; Adverse effect; Oncology; Clinical trial; Clinical Practice; Confidence interval; Response Evaluation Criteria in Solid Tumors; Liver function; Hepatocellular carcinoma; Phases of clinical research","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1453895,0.001238701,0.006033202,0.008471762,0.00163017,0.0151609,0.005491751,0.01118197,0.008744595],"category_scores_gemma":[0.4931189,0.001758368,0.002298836,0.0183782,0.009845356,0.01707895,0.005856739,0.01149784,0.002049888],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01077432,"about_ca_system_score_gemma":0.01762336,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005701856,"about_ca_topic_score_gemma":0.01030693,"domain_scores_codex":[0.8230949,0.1014333,0.03979759,0.006901192,0.02735031,0.001422661],"domain_scores_gemma":[0.3158821,0.5201213,0.06706217,0.01720828,0.07304446,0.006681746],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001072069,0.0002336203,0.00840683,0.08443484,0.003424926,0.0003125314,0.001840165,0.0004245588,0.0002005171,0.03278636,0.1199803,0.7468835],"study_design_scores_gemma":[0.0009137515,0.0005642403,0.009440973,0.5352965,0.00315044,0.000990205,0.003669768,0.001159661,0.0004275407,0.04722733,0.3968842,0.0002754192],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"commentary","genre_scores_codex":[0.001385798,0.7101822,0.00193264,0.2734602,0.007596835,0.0001374102,0.0003196333,0.00004555111,0.004939815],"genre_scores_gemma":[0.06602009,0.7317483,0.01435917,0.1688961,0.01713448,0.0005122808,0.0005748785,0.0001577151,0.0005969328],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.1453895,"threshold_uncertainty_score":0.7689025,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4227379028771812,"score_gpt":0.3924627215105821,"score_spread":0.03027518136659912,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}